ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,00%
Bitcoin
62.676,81
-0,34%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) News

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ARTH
DatumZeitQuelleÜberschriftSymbolFirma
22/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
23/05/202312h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
16/05/202312h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
20/04/202322h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
17/03/202311h04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
09/03/202314h08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
07/03/202315h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
16/02/202312h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
14/02/202322h48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
25/01/202321h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
23/01/202323h18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/01/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202222h52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
02/12/202213h26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
30/09/202222h37Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/08/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202223h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202212h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
26/08/202212h09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
22/08/202212h04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
18/08/202212h03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
17/08/202222h11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202222h24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202222h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202222h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/08/202223h24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202223h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202223h25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202223h25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/202223h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTH

Kürzlich von Ihnen besucht

COIN
BTCUSD
Bitcoin
FX
EURJPY
Euro vs Yen
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
DBI
SDXP
SDAX
CCOM
US30
US 30
NYSE
DIS
Walt Disney
TG
432
Arbor Metals
TG
MBG
MercedesBenz
NASDAQ
TSLA
Tesla
TG
LHA
Deutsche Lufthansa
TG
NOV
Novo Nordisk
NASDAQ
AAPL
Apple
TG
DBK
Deutsche Bank
DBI
MDAX
MDAX
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten